These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Putting resistance to the test. Daar ES Posit Living; 2001 Apr; 10(3):15-6, 43-6. PubMed ID: 11548369 [No Abstract] [Full Text] [Related]
4. [Resistance to antiretroviral drugs: a clinical, public health and health policy debate]. Guerra Romero L; Parras Vázquez F Med Clin (Barc); 2000 Oct; 115(11):428-30. PubMed ID: 11093847 [No Abstract] [Full Text] [Related]
5. HIV suppression and risk of drug resistance mutations. Phillips AN; Loveday C; Johnson MA AIDS; 1998 Oct; 12(14):1930. PubMed ID: 9792396 [No Abstract] [Full Text] [Related]
6. [Incorporation of the test of resistance to antiretroviral drugs in clinical practice]. Soriano V; Briones C Med Clin (Barc); 1999 Mar; 112(11):412-5. PubMed ID: 10231774 [No Abstract] [Full Text] [Related]
7. HIV drug resistance testing: an update for the clinician. Rice HL; Zolopa AR AIDS Clin Care; 2001 Oct; 13(10):89-91, 94-6, 100. PubMed ID: 11590921 [No Abstract] [Full Text] [Related]
8. Antiretroviral update: recent advances expand options for patients with HIV. Santhanam H; Goins M Adv Nurse Pract; 2004 Nov; 12(11):53-4, 56. PubMed ID: 15559568 [No Abstract] [Full Text] [Related]
9. [HIV infection. Virus resistance: development and prevention]. Link R; Miller V; Fätkenheuer G; Manegold C; Harrer T Med Monatsschr Pharm; 1999 Mar; 22(3):86-8. PubMed ID: 10223868 [No Abstract] [Full Text] [Related]
10. Salvage therapy for patients failing their current antiretroviral regimen. Albrecht MA AIDS Clin Rev; 2000-2001; ():139-91. PubMed ID: 10999220 [No Abstract] [Full Text] [Related]
11. [Biological basis for generating resistance to antiretroviral drugs]. Alcamí J; Delgado R; Menéndez-Arias L Enferm Infecc Microbiol Clin; 2001 Feb; 19(Monografico):3-13. PubMed ID: 11428056 [No Abstract] [Full Text] [Related]
12. [German-Austrian guidelines for antiretroviral therapy of HIV infection. (July, 2002, update)]. Brockmeyer NH; ; Dtsch Med Wochenschr; 2003 May; 128 Suppl 1():S7-18. PubMed ID: 12736863 [No Abstract] [Full Text] [Related]
13. How testing for HIV resistance influences therapeutic decision making. Analysis of a sample of 600 clinicians. Mascolini M; Wensing AM; Boucher CA IAPAC Mon; 2001 Mar; 7(3):85-90. PubMed ID: 11697306 [No Abstract] [Full Text] [Related]
14. Resistance and cross-resistance with saquinavir and other HIV protease inhibitors: theory and practice. Roberts NA; Craig JC; Sheldon J AIDS; 1998 Mar; 12(5):453-60. PubMed ID: 9543442 [No Abstract] [Full Text] [Related]
15. International perspectives on antiretroviral resistance. Clinical utility of resistance testing: retrospective and prospective data supporting use and current recommendations. Haubrich R; Demeter L J Acquir Immune Defic Syndr; 2001 Mar; 26 Suppl 1():S51-9. PubMed ID: 11265001 [TBL] [Abstract][Full Text] [Related]
17. The role of viral dynamics in the pathogenesis of HIV disease and implications for antiviral therapy. Havlir DV; Richman DD Springer Semin Immunopathol; 1997; 18(3):267-83. PubMed ID: 9089949 [No Abstract] [Full Text] [Related]
18. New insights into HIV resistance testing: nursing guidelines and implications. Kirton CA; Kurtyka D; Sterken DJ J Assoc Nurses AIDS Care; 2007; 18(3):74-86. PubMed ID: 17570302 [TBL] [Abstract][Full Text] [Related]
19. The daunting challenge of keeping HIV suppressed. Cohen J Science; 1997 Jul; 277(5322):32-3. PubMed ID: 9229768 [No Abstract] [Full Text] [Related]
20. New guidelines for HIV treatment; resistance testing now recommended. AIDS Treat News; 2000 Feb; (No 337):5-6. PubMed ID: 11367208 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]